The global peripheral artery disease market size reached US$ 4.6 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.42% during 2023-2032.
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).
In addition, governments of several countries are undertaking initiatives to spread awareness about the benefits of PAD devices, which is positively influencing the market. Besides this, the rising prevalence of cardiac diseases among individuals around the world is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on mergers and acquisitions (M&A) to strengthen PAD treatment capabilities. These players are also focusing on various developmental strategies, which are projected to bolster their overall profitability.
2. What is the expected growth rate of the global peripheral artery disease market during 2024-2032?
3. What are the key factors driving the global peripheral artery disease market?
4. What has been the impact of COVID-19 on the global peripheral artery disease market?
5. What is the breakup of the global peripheral artery disease market based on the type?
6. What are the key regions in the global peripheral artery disease market?
7. Who are the key players/companies in the global peripheral artery disease market?
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).
Peripheral Artery Disease Market Trends:
At present, there is a rise in the geriatric population across the globe. This, along with changing lifestyles of individuals, increasing adoption of unhealthy dietary patterns, alcoholism, and obesity on account of lack of physical activities, represents one of the key factors driving the market. Moreover, there is an increase in the adoption of minimally invasive surgeries (MIS) due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, faster recovery times, and less stress on the immune system. This, coupled with the expanding healthcare industry, is propelling the growth of the market.In addition, governments of several countries are undertaking initiatives to spread awareness about the benefits of PAD devices, which is positively influencing the market. Besides this, the rising prevalence of cardiac diseases among individuals around the world is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on mergers and acquisitions (M&A) to strengthen PAD treatment capabilities. These players are also focusing on various developmental strategies, which are projected to bolster their overall profitability.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and end user.Breakup by Type:
- Peripheral Angioplasty Balloons
- Peripheral Stents
- Peripheral Catheters
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.Key Questions Answered in This Report
1. How big is the global peripheral artery disease market?2. What is the expected growth rate of the global peripheral artery disease market during 2024-2032?
3. What are the key factors driving the global peripheral artery disease market?
4. What has been the impact of COVID-19 on the global peripheral artery disease market?
5. What is the breakup of the global peripheral artery disease market based on the type?
6. What are the key regions in the global peripheral artery disease market?
7. Who are the key players/companies in the global peripheral artery disease market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Peripheral Artery Disease Market
6 Market Breakup by Type
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton Dickinson
- Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Koninklijke Philips N.V.
- Medtronic plc
- Terumo Corporation.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 4.6 Billion |
| Forecasted Market Value ( USD | $ 7.4 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
